InvestorsHub Logo
Followers 7
Posts 119
Boards Moderated 0
Alias Born 09/28/2015

Re: plexrec post# 82848

Friday, 12/09/2016 1:32:38 PM

Friday, December 09, 2016 1:32:38 PM

Post# of 473746
"Shares of Biogen are well off their highs after the company in presentation slides for the Clinical Trials on Alzheimer's Disease meeting disclosed an serious adverse event occurred in a patient taking its treatment for early Alzheimer's disease aducanumab. The patient had a treatment-related seizure and loss of pulse. Biogen also disclosed two patient deaths, with are considered unrelated to treatment, according to Biogen."

http://thefly.com/landingPageNews.php?id=2475177&headline=BIIB-Biogen-off-highs-after-disclosing-serious-adverse-event-in-Alzheimers-trial
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News